| This week's sponsor is TD2. | |  | |
Today's Rundown Featured Story | | | Monday, January 8, 2018 On the first day of the big biotech conference that is J.P. Morgan, Celgene has come right out on day one with M&A news. |
|
|
| This week's sponsor is Veeva. | |  | [Webinar] Tufts eClinical Landscape Study: Q&A with Industry Experts
January 16, 2018 | 2pm ET / 11am PT
Hear expert analysis of the 2017 eClinical Landscape Survey, one of the largest, most in-depth surveys of clinical data management professionals that shows the impact of database build delays on trial timelines, as well as the projected increase of data source usage. Register Now |
Top Stories Sunday, January 7, 2018 A new journal paper published late last week revealed that a “cutting” element of the CRISPR-Cas9 gene-editing technique could be under threat from the body’s own immune system. Sunday, January 7, 2018 Big Pharma Pfizer, on the eve of J.P. Morgan, the biggest biopharma dating event of the year, will cut around 300 jobs and a number of earlier stage projects from its neuroscience pipeline. Monday, January 8, 2018 Astellas, like many of our industry peers, prioritizes innovation. What sets Astellas apart, however, is how we function at the intersection where our “Science First” approach meets the flexibility we’ve built into our innovation infrastructure. Monday, January 8, 2018 Axovant’s run of bad news shows no signs of letting up, with negative results in a phase 2b trial in Lewy body dementia spelling the end for lead candidate intepirdine. Monday, January 8, 2018 Novo Nordisk has gone public with its €2.6 billion ($3.1 billion) bid to acquire Ablynx. The Danish company had two takeover offers rejected by Ablynx last month, prompting it to go public with its intentions to dial up the pressure on its target. Monday, January 8, 2018 Alnylam has stepped up its commitment to pioneering RNAi drug patisiran by retooling its agreement with Sanofi. The revised deal returns full global control of the ATTR amyloidosis drug to Alnylam and sees Sanofi obtain worldwide rights to hemophilia candidate fitusiran. Monday, January 8, 2018 Pfizer has set up a new partnering network to try to foster collaborations with top-tier universities, shortly after stripping out a chunk of its in-house R&D effort. Monday, January 8, 2018 After running four months without a proper new name following the completion of the $7.4 billion merger, INC Research and inVentiv Health were finally reborn as Syneos Health. Monday, January 8, 2018 Welcome to the first official day of the biggest biopharma event of the year, and we’ve had a real mixture of data, mergers and rejigs already. Over the week we’ll be reporting from San Francisco with the latest updates, interviews and our own biotech panel, which is running tomorrow morning. Monday, January 8, 2018 Shire has a penchant for making headlines at the J.P. Morgan Healthcare Conference, and it did so again early Monday. | This week's sponsor is Protea Biosciences. | | Protea's “BIOPHARMA” Assets Available For Sale in Morgantown, WV (Ch. 11 Debtor) - Cancer-Diagnostic Protocols, Lab EQ, & Licenses ($1.15MM Min)
- Stalking Horse Bid at $1.0MM Already Filed; Sale Hearing Date 01/24/18
- Small Molecule Analytics Business, EQ, & Cust. AR + $75.0MM NOLs ($1.0MM Min)
All assets to be sold via 363-Sale Auctions (No. Distr. of WV BK Court - Case: 17-1200) Bids are due by January 18, 2018 (Unless Extended) Contact: Jack Teitz, CRO for Additional Information: 412-855-7625 |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Seton Hall Don’t miss this educational program trusted by multi-national companies as part of their employee’s compliance training. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating in the Asia-Pacific region. Visit event page for session topics. Sponsored by: Agilent This Agilent intact protein analysis includes: Sponsored by: Veeva Systems Regulatory leaders share challenges and best practices from a lack of standardization, manual processes, and fragmented systems. Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. |
|
